Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kymera Therapeutics, Inc. (KYMR)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 62,339,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Kymera Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s proprietary targeted protein degradation platform, which Co. refers to as Pegasus™, allows Co. to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Co. has utilized its Pegasus™ platform to design protein degraders focused in the areas of immunology-inflammation and oncology, and Co. continues to apply its platform's capabilities to additional therapeutic areas.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 414,105 1,300,163
Total Buy Value $0 $0 $5,301,325 $25,027,880
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 2 8
Total Shares Sold 846,935 906,367 906,367 2,944,621
Total Sell Value $35,475,904 $37,488,861 $37,488,861 $99,885,268
Total People Sold 5 6 6 7
Total Sell Transactions 16 19 19 49
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 204
  Page 5 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mainolfi Nello Chief Executive Officer   •       •      –    2022-01-10 4 OE $2.08 $46,727 D/D 22,465 494,664     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-12-16 4 OE $2.08 $16,640 D/D 8,000 472,199     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2021-12-03 4 AS $53.31 $535,637 D/D (10,000) 17,514     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2021-12-03 4 OE $2.08 $20,800 D/D 10,000 27,514     -
   Gollob Jared Chief Medical Officer   •       –      –    2021-11-02 4 AS $62.89 $948,063 D/D (14,996) 24,657     -
   Gollob Jared Chief Medical Officer   •       –      –    2021-11-02 4 OE $2.08 $31,192 D/D 14,996 39,653     -
   Gollob Jared Chief Medical Officer   •       –      –    2021-11-01 4 AS $60.40 $2,625,595 D/D (42,497) 24,657     -
   Gollob Jared Chief Medical Officer   •       –      –    2021-11-01 4 OE $1.31 $35,783 D/D 24,607 67,154     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-10-11 4 AS $53.58 $346,590 D/D (6,456) 464,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-10-11 4 OE $2.08 $13,428 D/D 6,456 470,655     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-10-08 4 AS $55.56 $2,357,946 D/D (41,544) 464,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-10-08 4 OE $2.08 $86,412 D/D 41,544 505,743     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2021-09-03 4 AS $60.05 $601,180 D/D (10,000) 7,256     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2021-09-03 4 OE $2.08 $20,800 D/D 10,000 17,256     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-08-19 4 OE $2.08 $24,960 D/D 12,000 464,199     -
   Chesworth Richard Chief Scientific Officer   •       –      –    2021-08-17 4 AS $49.90 $2,720,182 D/D (54,000) 0     -
   Chesworth Richard Chief Scientific Officer   •       –      –    2021-08-17 4 OE $20.00 $1,080,000 D/D 54,000 54,000     -
   Atlas Venture Associates X, Llc 10% Owner   –       –       •   2021-08-11 4 S $61.00 $14,770,113 D/D (242,133) 0     -
   Booth Bruce Director   –       •      –    2021-08-11 4 S $61.00 $14,770,113 I/I (242,133) 0     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-08-04 4 AS $60.03 $62,253 D/D (1,037) 452,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-08-04 4 OE $2.08 $2,157 D/D 1,037 453,236     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-08-03 4 AS $60.07 $340,533 D/D (5,669) 452,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-08-03 4 OE $2.08 $11,792 D/D 5,669 457,868     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-08-02 4 AS $60.21 $1,414,404 D/D (23,456) 452,199     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2021-08-02 4 OE $2.08 $48,788 D/D 23,456 475,655     -
  204 Records found
  1  2  3  4  5  6  7  8  9   
  Page 5 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us